TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
- Status
- COMPLETED
- Phase
- PHASE4
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE1
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab and Olaparib in Cervical Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1